Abstract
Hyporeninemic hypoaldosteronism has been reported in only a few cases with methylmalonic acidemia (MMA) and has been attributed to the renal involvement. This study aims to investigate renin-aldosterone levels along with the renal functions of the patients with organic acidemia. This is a cross-sectional study conducted in patients with MMA, propionic acidemia (PA), and isovaleric acidemia (IVA). Serum renin, aldosterone, sodium, and potassium levels were measured, and glomerular filtration rates (GFR) were calculated. Comparisons were made between the MMA and non-MMA (PA+IVA) groups. Thirty-two patients (MMA:PA:IVA = 14:13:5) were included. The median GFR was significantly lower in the MMA group than in the non-MMA group (p < 0.001). MMA patients had the highest incidence of kidney damage (71.4%), followed by PA patients (23%), while none of the IVA patients had reduced GFR. GFR positively correlated with renin levels (p = 0.015, r = 0.433). Although renin levels were significantly lower in the MMA group than the non-MMA group (p = 0.026), no significant difference in aldosterone levels was found between the two groups. Hyporeninemic hypoaldosteronism was found in 3 patients with MMA who had different stages of kidney damage, and fludrocortisone was initiated, which normalized serum sodium and potassium levels.
Conclusions: This study, which has the largest number of patients among the studies investigating the renin-angiotensin system in organic acidemias to date, has demonstrated that hyporeninemic hypoaldosteronism is not a rare entity in the etiology of hyperkalemia in patients with MMA, and the use of fludrocortisone is an effective treatment of choice in selected cases.
What is Known: • Hyperkalemia may be observed in cases of methylmalonic acidemia due to renal involvement and can be particularly prominent during metabolic decompensation. • Hyporeninemic hypoaldosteronism has been reported to be associated with hyperkalemia in only a few cases of methylmalonic acidemia. | |
What is New: • Hyporeninemic hypoaldosteronism was found in one-fifth of cases with methylmalonic acidemia. • Fludrocortisone therapy leads to the normalization of serum sodium and potassium levels. |
Similar content being viewed by others
Data availability
Data are available on request only due to ethical or legal reasons.
Abbreviations
- CKD:
-
Chronic kidney disease
- GFR:
-
Glomerular filtration rate
- IVA:
-
Isovaleric acidemia
- KDIGO:
-
Kidney Disease Improving Global Outcomes
- MMA:
-
Methylmalonic acidemia
- PA:
-
Propionic acidemia
- PRA:
-
Plasma renin activity
- UNaK:
-
Urine sodium to potassium ratio
References
Dimitrov B, Molema F, Williams M, Schmiesing J, Mühlhausen C, Baumgartner MR, Schumann A, Kölker S (2021) Organic acidurias: major gaps, new challenges, and a yet unfulfilled promise. J Inherit Metab Dis 44:9–21. https://doi.org/10.1002/jimd.12254
Dao M, Arnoux J-B, Bienaimé F et al (2021) Long-term renal outcome in methylmalonic acidemia in adolescents and adults. Orphanet J Rare Dis 16:220. https://doi.org/10.1186/s13023-021-01851-z
Shchelochkov OA, Manoli I, Sloan JL et al (2019) Chronic kidney disease in propionic acidemia. Genet Med. 21:2830–5. https://doi.org/10.1038/s41436-019-0593-z
Weidmann P, Reinhart R, Maxwell MH, Rowe P, Coburn JW, Massry SG (1973) Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J Clin Endocrinol Metab 36:965–77. https://doi.org/10.1210/jcem-36-5-965
Batlle D, Arruda J (2018) Hyperkalemic forms of renal tubular acidosis: clinical and pathophysiological aspects. Adv Chronic Kidney Dis 25:321–33. https://doi.org/10.1053/j.ackd.2018.05.004
Sousa AG, Cabral JV, El-Feghaly WB, de Sousa LS, Nunes AB (2016) Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management. World J Diabetes 7:101–11. https://doi.org/10.4239/wjd.v7.i5.101
Rajkumar V, Waseem M (2020) Hypoaldosteronism. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Isl StatPearls Publ. https://www.ncbi.nlm.nih.gov/books/NBK555992/
D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr. 150:259–63. https://doi.org/10.1007/BF01955526
Ohura T, Kikuchi M, Abukawa D, Hanamizu H, Aikawa J, Narisawa K, Tada K, Yunoki H (1990) Type 4 renal tubular acidosis (subtype 2) in a patient with methylmalonic acidaemia. Eur J Pediatr. 150:115–8. https://doi.org/10.1007/BF02072052
Pela I, Gasperini S, Pasquini E, Donati MA (2006) Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function. Clin Nephrol. 66:63–6. https://doi.org/10.5414/cnp66063
Hartman D, Sagnella GA, Chesters CA, MacGregor GA (2004) Direct renin assay and plasma renin activity assay compared. Clin Chem 50:2159–61. https://doi.org/10.1373/clinchem.2004.033654
Ng DK, Pierce CB (2021) Kidney disease progression in children and young adults with pediatric CKD: epidemiologic perspectives and clinical applications. Semin Nephrol 41:405–15. https://doi.org/10.1016/j.semnephrol.2021.09.002
Summary of recommendation statements (2013) Kidney Int Suppl 3:5–14. https://doi.org/10.1038/kisup.2012.77
Arend LJ, Thompson CI, Brandt MA, Spielman WS (1986) Elevation of intrarenal adenosine by maleic acid decreases GFR and renin release. Kidney Int 30:656–61. https://doi.org/10.1038/ki.1986.236
Charbit-Henrion F, Lacaille F, McKiernan P et al (2015) Early and late complications after liver transplantation for propionic acidemia in children: a two centers study. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg 15:786–91. https://doi.org/10.1111/ajt.13027
Palmer BF (2015) Regulation of potassium homeostasis. Clin J Am Soc Nephrol 10:1050–60. https://doi.org/10.2215/CJN.08580813
DeFronzo RA (1980) Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int 17:118–134. https://doi.org/10.1038/ki.1980.14
Martinez-Aguayo AG, Campino C, Rodriguez-Fernandez M et al (2020) Urinary sodium-to-potassium ratio and plasma renin and aldosterone concentrations in normotensive children: implications for the interpretation of results. J Hypertens 38:671–8. https://doi.org/10.1097/HJH.0000000000002324
Funding
This work was funded by Istanbul University-Cerrahpasa, Scientific Research Projects Coordination Unit with the project number 35848.
Author information
Authors and Affiliations
Contributions
G.T. wrote the main manuscript text, G.T. and S.A. collected the samples, all authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Istanbul University-Cerrahpaşa (Date: 3.3.2021 / No: 43399). Written informed consent was obtained from the parents.
Consent to participate
Written informed consent was obtained from the parents.
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tarçın, G., Ahmadzada, S., Saygılı, S. et al. Evaluating renin and aldosterone levels in children with organic acidemia—therapeutic experience with fludrocortisone. Eur J Pediatr 182, 5447–5453 (2023). https://doi.org/10.1007/s00431-023-05221-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05221-8